Table 2.
Univariate and multivariate regression analyses between early recurrence and non-recurrence groups in the training cohort.
| Parameter | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| Hazard Ratio | P value | Hazard Ratio | P value | |
| Age | 0.98 (0.94, 1.01) | 0.213 | ||
| Gender | 1.44 (0.43, 4.78) | 0.556 | ||
| HBsAg | 0.96 (0.37, 2.52) | 0.934 | ||
| HBV-DNA | 2.75 (1.22, 6.22) | 0.015a | 1.24 (0.25, 6.20) | 0.794 |
| PLT | 1.00 (0.99, 1.01) | 0.050 | ||
| ALT | 1.00 (0.99, 1.01) | 0.646 | ||
| ALB | 1.02 (0.94, 1.10) | 0.676 | ||
| PT | 1.01 (0.90, 1.15) | 0.823 | ||
| Serum AFP level | ||||
| <20 | ||||
| 20–400 | 2.70 (1.10, 6.64) | 0.031a | 1.36 (0.26, 7.19) | 0.719 |
| >400 | 7.59 (2.15, 26.84) | 0.002a | 3.96 (0.44, 35.71) | 0.220 |
| Child-Pugh score | 0.39 (0.11, 1.36) | 0.126 | ||
| ALBI grade | ||||
| 1 | ||||
| 2 | 1.70 (0.67, 4.29) | 0.265 | ||
| 3 | 0.32 (0.03, 3.03) | 0.318 | ||
| CTC status | 5.16 (2.23, 11.92) | <0.001a | 7.02 (2.07, 28.38) | 0.003a |
| Tumour size | 1.19 (1.04, 1.37) | 0.014a | 1.01 (0.79, 1.29) | 0.924 |
| Tumour number | ||||
| 1 | ||||
| 2 | 0.972 | |||
| 3 | 0.974 | |||
| Ultrasomics score | 412.17 (43.91, 3868.60) | <0.001a | 148.65 (25.49, 1741.72) | <0.001a |
| Treatment | ||||
| Resection | ||||
| Transplantation | 0.89 (0.39, 2.02) | 0.780 | ||
| Ablation | 0.46 (0.15, 1.41) | 0.176 | ||
Note.—Data in parentheses are the 95% confidence intervals. Significant variables with p < 0.10 in the univariate analysis were included in the multivariate logistic regression analysis.
a
P value < 0.05